ENGINEERED IMINE REDUCTASES AND METHODS FOR THE REDUCTIVE AMINATION OF KETONE AND AMINE COMPOUNDS
The present disclosure provides engineered polypeptides having imine reductase activity, polynucleotides encoding the engineered imine reductases, host cells capable of expressing the engineered imine reductases, and methods of using these engineered polypeptides with a range of ketone and amine substrate compounds to prepare secondary and tertiary amine product compounds.
1 . An engineered polypeptide having imine reductase activity comprising an amino acid sequence having at least 80% sequence identity to SEQ ID NO: 2 and one or more residue differences as compared to the sequence of SEQ ID NO: 2 at residue positions selected from X198, X111, X136, X156, X197, X201, X259, X280, X292, and X293.
2 . The engineered polypeptide of claim 1 in which the residue differences are selected from X198E/A/H/P/S, X111M/Q/S, X136G, X156G/I/QJS/T/V, X197I/P, X201L, X259E/H/I/L/M/S/T, X280L, X292C/G/I/P/S/T/V/Y, and X293H/I/K/L/N/QJT/V.
3 . The engineered polypeptide of any one of claim 1 in which the amino acid sequence comprises at least a combination of residue differences selected from:
(a) X111M, X156T, X198H, X259M, X280L, X292V, and X293H;
(b) X156T, X197P, X198H, X259H, X280L, X292P, and X293H;
(c) X111M, X136G, X156S, X197I, X198H, X201L, X259H, X280L, X292V, and X293H;
(d) X197I, X198E, X259M, and X280L;
(e) X156T, X197I, X198E, X201L, X259H, X280L, X292V, and X293H;
(f) X111M, X136G, X198H, X259M, X280L, X292S, and X293H; and
(g) X156V, X197P, X198E, X201L, X259M, X280L, and X292T.
4 . The engineered polypeptide of claim 1 , wherein said polypeptide is capable of converting substrate compound (1a) pyruvate,
and substrate compound (2b) butylamine
to product compound (3b), N-2-(butylamino)propanoic acid,
under suitable reaction conditions.
5 . The engineered polypeptide of claim 1 , wherein said polypeptide is capable of converting substrate compound (1b) cyclohexanone,
and substrate compound (2a) L-norvaline
to product compound (3c), (S)-2-(cyclohexylamino)pentanoic acid,
under suitable reaction conditions.
6 . The engineered polypeptide of claim 1 , wherein said polypeptide is capable of converting substrate compound (1b) cyclohexanone,
and substrate compound (2b) butylamine
to product compound (3d), N-butylcyclohexanamine,
under suitable reaction conditions.
7 . The engineered polypeptide of claim 1 , wherein said polypeptide is capable of converting substrate compound (1i),
and substrate compound (2b)
to product compound (3n),
under suitable reaction conditions.
8 . The engineered polypeptide of claim 1 , wherein said polypeptide is capable of converting substrate compound (1j),
and substrate compound (2b)
to product compound (3o),
under suitable reaction conditions.
9 . An engineered polynucleotide encoding the engineered polypeptide of claim 1 .
10 . A vector comprising the engineered polynucleotide of claim 9 .
11 . A host cell comprising the vector of claim 10 .
12 . A host cell comprising the vector of claim 11 .
13 . A process for preparing an amine compound of formula (III),
wherein
R 1 and R 2 groups are independently selected from a hydrogen atom, and optionally substituted alkyl, alkenyl, alkynyl, alkoxy, carboxy, aminocarbonyl, heteroalkyl, heteroalkenyl, heteroalkynyl, carboxyalkyl, aminoalkyl, haloalkyl, alkylthioalkyl, cycloalkyl, aryl, arylalkyl, heterocycloalkyl, heteroaryl, and heteroarylalkyl; and optionally R 1 and R 2 are linked to form a 3-membered to 10-membered ring;
R 3 and R 4 groups are independently selected from a hydrogen atom, and optionally substituted alkyl, alkenyl, alkynyl, alkoxy, carboxy, aminocarbonyl, heteroalkyl, heteroalkenyl, heteroalkynyl, carboxyalkyl, aminoalkyl, haloalkyl, alkylthioalkyl, cycloalkyl, aryl, arylalkyl, heterocycloalkyl, heteroaryl, and heteroarylalkyl, with the proviso that both R 3 and R 4 cannot be hydrogen; and optionally R 3 and R 4 are linked to form a 3-membered to 10-membered ring; and
optionally, the carbon atom and/or the nitrogen indicated by * is chiral;
the process comprising contacting
a compound of formula (I),
wherein
R 1 , and R 2 are as defined above;
and
a compound of formula (II),
wherein
R 3 , and R 4 are as defined above;
with an engineered polypeptide having imine reductase activity in presence of a cofactor under suitable reaction conditions, optionally wherein the engineered polypeptide is:
(a) derived from a naturally occurring opine dehydrogenase selected from: opine dehydrogenase from Arthrobacter sp. strain 1C (SEQ ID NO: 2), D-octopine dehydrogenase from Pecten maximus (SEQ ID NO: 102), ornithine dehydrogenase from Lactococcus lactis K1 (SEQ ID NO: 104), N-methyl-L-amino acid dehydrogenase from Pseudomonas putida (SEQ ID NO: 106), β-alanopine dehydrogenase from Cellana grata (SEQ ID NO: 108), and tauropine dehydrogenase from Suberites domuncula (SEQ ID NO: 110); or
(b) an engineered polypeptide of claim Error! Reference source not found.
14 . The process of claim 13 in which R 3 and R 4 are linked to form a 3-membered to 10-membered ring.
15 . The process of claim 13 in which the substrate compound of formula (II) is selected from methylamine, dimethylamine, isopropylamine, butylamine, isobutylaminel, L-norvaline, aniline, (S)-2-aminopent-4-enoic acid, pyrrolidine, and hydroxypyrrolidine.
16 . The process of claim 13 in which at least one of R 1 and R 2 of the compound of formula (I) is linked to at least one of R 3 and R 4 of the amine compound of formula (II), whereby the process for preparing the amine compound of formula (III) comprises an intramolecular reaction.
17 . The process of claim 13 in which the suitable reaction conditions comprise
(a) substrate loading at about 10 g/L to 100 g/L;
(b) about 0.1 g/L to about 50 g/L of the engineered polypeptide;
(c) about 0.05 g/L (0.001 M) to about 2.5 g/L (0.050 M) of NAD(P)H;
(d) a pH of about 6 to 10;
(e) temperature of about 20° to 50° C.; and
(f) reaction time of 2-120 hrs.